-
Nutrition and Dietary Supplements
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Role of n-3 series polyunsaturated fatty acids in cardiovascular disease prevention
Review
(1452) Views (1136) Full article downloads
Authors: Lee AH, Hiramatsu N
Published Date September 2011
Volume 2011:3 Pages 93 - 100
DOI: http://dx.doi.org/10.2147/NDS.S15443
Andy H Lee1, Naoko Hiramatsu21School of Public Health, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia; 2Laboratory of Nutritional Science, School of Human Science and Environment, University of Hyogo, Himeji, Hyogo, Japan
Abstract: Cardiovascular disease is a major cause of morbidity and mortality worldwide. Its prevention through a healthy lifestyle and appropriate diet is important. Omega-3 polyunsaturated fatty acids (n-3 PUFA) therapy has shown promise in both primary and secondary prevention of cardiovascular disease. This commentary discusses the nutritional role of n-3 PUFA, including its metabolism and physiological role, comparison with n-6 series PUFA, as well as complications due to deficiency. Clinical use of n-3 PUFA for the prevention and treatment of cardiovascular disease, recommended intake, and potential adverse effects will also be examined. The available scientific evidence suggests that its supplementation and clinical use ranging from 0.4 to 1 g/day can provide tangible benefits. However, further studies are required to determine optimal dosing and the relative ratio of docosahexaenoic acid and eicosapentaenoic acid that provides maximal cardioprotection and treatment of cardiovascular disease.
Keywords: alpha-linolenic acid, docosahexaenoic acid, eicosapentaenoic acid, cardiovascular disease, fish oil, polyunsaturated fatty acids
Readers of this article also read:
Clinical evidence supporting the use of an activated clinoptilolite suspension as an agent to increase urinary excretion of toxic heavy metals
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Cholesterol-lowering phytosterols: factors affecting their use and efficacy
Use of dietary supplements among US adults with asthma
Clinical potential for the use of probiotics in the management of respiratory conditions and cold- and influenza-like symptoms
Efficacy of a novel, biologically active food supplement in type 2 diabetes mellitus: a patient-blinded, prospective, clinical trial
Update on critical evidence for use of carnitine analogs in clinical practice in CNS disorders
Evaluation of bovine-derived lacteal complex supplementation on gene expression in BALB/c mice
Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-κB signaling
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Clinical evidence supporting the use of an activated clinoptilolite suspension as an agent to increase urinary excretion of toxic heavy metals
- Polyphenols as dietary supplements: A double-edged sword
- Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
- Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee




